Clinical trial
Effects of Growth Hormone on the Nitric Oxide Pathway
NCT00470002 · Hannover Medical School, Other · Completed
Key facts
| NCT number | NCT00470002 |
|---|---|
| Title | Effects of Growth Hormone on the Nitric Oxide Pathway |
| Official title | Effects of Growth Hormone (GH) on Parameters of the Nitric Oxide (NO) Pathway |
| Lead sponsor | Hannover Medical School, Other |
| Collaborators | Pharmacia Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | Somatropin |
| Enrollment | 16 |
| Start date | May 1, 2004 |
| Completion | Jan 1, 2005 |
| First posted | May 7, 2007 |
| Last update posted | May 7, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: